Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer (Q41637922)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article published on March 1, 1992
Language Label Description Also known as
English
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer
scientific article published on March 1, 1992

    Statements

    title
    Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    1371564
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1371564
    retrieved
    19 September 2022

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q41637922&oldid=2128152026"